Search results

Page results

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• Alzheimer’s disease acquired from historic medical treatments

  Five cases of Alzheimer’s disease are believed to have arisen as a result of medical treatments decades earlier, reports a team of UCL and UCLH researchers. 

• First patient treated on new advanced radiotherapy machine to improve cancer treatment

  Read more about the Halcyon linear accelerator, aimed at making cancer treatment faster, more comfortable, and more precise for patients.

• Faster diagnosis pathway for gynaecology

  This page is for patients who have been referred by their GP to a gynaecology specialist because their symptoms need further tests.

• Tandem T:slim software update

  From the 23rd January, there will be a staggered rollout of the Tandem t:slim™ 7.7 Control IQ software.

• Feeling sick - what you can do (Easy read)

  This page offers advice to patients who are feeling sick.

• UCLH Grafton Way Elective Surgical Hub receives GIRFT accreditation

  We’re delighted to announce that our Grafton Way Elective Surgical Hub has been successfully accredited as an elective surgical hub delivering high standards in clinical and operational practice.

• Patients more likely to be admitted to critical care after surgery if a bed is available

  Bed availability is a “significant” factor in determining whether or not a patient is admitted to a critical care bed after surgery, questioning whether some are getting the care they need, a new study from researchers at UCL and UCLH has found for the first time.

• Oxbryta (Voxelotor) withdrawal from the UK market in the treatment of Sickle Cell Disorder in people aged 12 years and older

  Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.

• Obesity/High body Mass Index– what are the risks?

  This page is for patients with obesity who are waiting for scheduled surgery.